Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management.

Olga Benítez HidalgoM Fernanda Martinez GarciaAgustin Bescos CabestreJuan Carlos Juarez GimenezMercedes Gironella MesaFrancesc Bosch Albareda

Published in: Clinical case reports (2022)

Extended half-life FIX (EHL-FIX) concentrates have been developed with the purpose of reducing the frequency of infusions in patients with severe or moderate hemophilia B. We describe the case of a 63-year-old patient with severe hemophilia B (sHB) treated with FIX-Fc fusion protein (rFIXFc) who underwent neurosurgery.

Keyphrases

early onset
case report
drug induced
patients undergoing
cardiac surgery
high intensity